Quent Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12K Sell
18
-52
-74% -$7.26K ﹤0.01% 1386
2025
Q4
$11.5K Buy
70
+17
+32% +$2.66K ﹤0.01% 1122
2025
Q3
$7.08K Buy
+53
New +$6.44K ﹤0.01% 1083
2025
Q2
Sell
-30
Closed -$3.82K 1030
2025
Q1
$3.82K Hold
30
﹤0.01% 1059
2024
Q4
$4.32K Buy
30
+7
+30% +$1K ﹤0.01% 1071
2024
Q3
$3.36K Hold
23
﹤0.01% 1170
2024
Q2
$2.9K Buy
23
+21
+1,050% +$3.29K ﹤0.01% 1171
2024
Q1
$368 Buy
2
+1
+100% +$190 ﹤0.01% 1322
2023
Q4
$180 Buy
+1
New +$156 ﹤0.01% 1308

Other funds holding RGEN

Quent Capital's RGEN Position: Q1 2026 in Review

Quent Capital reduced its Repligen (RGEN) stake by 74% in Q1 2026, selling an estimated $7.26K and leaving 18 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Quent Capital first reported a position in RGEN in Q4 2023 and has held it in 9 quarters since. The position peaked at $11.5K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Quent Capital held 18 shares of Repligen worth $2.12K as of Q1 2026.
  • Quent Capital sold 52 Repligen shares in Q1 2026, an estimated $7.26K.
  • Repligen made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1386 holding.
  • Quent Capital first reported a position in Repligen in Q4 2023 and has held it in 9 quarters since.
  • Quent Capital's Repligen position peaked at $11.5K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.